American Society of Plastic Surgeons
Log In For Medical Professionals
 

Functional Nasal Surgery Relieves Chronic Headache for Some Patients

Nasal surgery to relieve obstructed breathing can reduce or eliminate chronic headaches in selected patients, reports a paper in the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Eighty-five percent of patients undergoing functional nasal surgery had at least partial improvement in their headaches, according to a research summary and update by Ahmed M. Afifi, MD, and colleagues of University of Wisconsin, Madison. They write, "These results suggest that the use of nasal surgery to improve headache symptoms is a viable treatment option in appropriately selected chronic headache patients."

Nasal Surgery Improves Headache by Addressing 'Contact Points'

The researchers analyzed available evidence from previous studies of nasal surgery to treat chronic headache. These procedures target "contact points" within the nose and sinuses, which are believed to serve as trigger points for chronic headaches. This type of surgery is often done as part of functional nasal surgery to relieve obstructed breathing. Functional nasal surgery has been shown to improve nasal airway breathing, allergy symptoms, and obstructive sleep apnea.

A systematic research review identified 39 studies reporting on 1,577 patients who underwent functional nasal surgery for treatment of headaches due to mucosal contact points. The most common procedures were surgery to address a deviated septum or excess sinus tissue. About half of the studies included endoscopic sinus surgery (ESS), often performed in patients with recurrent sinus infections.

The assembled data suggested that functional nasal surgery was highly effective in reducing or eliminating chronic headache symptoms. About 48 percent of patients reported that their headaches were cured after surgery, while another 37 percent had significant improvement in headache severity or frequency. Only 15 percent reported no change.

In a subset of studies, functional nasal surgery reduced the number of days with headache: from approximately 22 to six days per month. Ratings of headache pain were also significantly reduced.

Sometimes patients are selected for functional nasal surgery by a local anesthetic nerve block. Patients who had a positive result (relief from headache pain) on this nerve block test were more likely to have a good response to surgery. Outcomes also appeared better when ESS was performed as part of the surgery.

The new paper is the first systematic review of evidence demonstrating that "nasal mucosal contact points may be a viable surgical target to help improve headaches in appropriately selected patients," Dr. Afifi and coauthors write. The good responses to nasal surgery suggest "an important relationship between intranasal anatomy and headache feedback loops."

"Taken together, these results underscore the importance of a thorough diagnostic workup to help tailor individualized surgical treatment to each patient’s unique anatomy," the researchers write. But they emphasize that the specific procedures performed in the studies varied substantially, as well as the need for consistent diagnostic criteria to identify chronic headache patients who might benefit from functional nasal surgery.

"Functional nasal surgery is a viable option to improve headache symptoms in appropriately selected patients," Dr. Afifi and colleagues conclude. They highlight the need for well-controlled randomized trials, including careful selection criteria to identify patients most likely to benefit from this surgical approach to treatment for chronic headache.

Plastic and Reconstructive Surgery® is published by Wolters Kluwer.

Click here to read "Can Functional Nasal Surgery Treat Chronic Headaches? A Systematic Review"

Article: "Can Functional Nasal Surgery Treat Chronic Headaches? A Systematic Review" (doi: 10.1097/PRS.0000000000004989)

About Plastic and Reconstructive Surgery

For more than 70 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.

About ASPS

The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 8,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Logo

Patient Care Center